会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • SECURITY APPARATUS AND METHOD FOR ALL-IN-ONE MOBILE DEVICE USING SECURITY PROFILE
    • 使用安全简档的一体机移动设备的安全设备和方法
    • US20090094670A1
    • 2009-04-09
    • US11951908
    • 2007-12-06
    • Wonjoo ParkDongho KangKiyoung Kim
    • Wonjoo ParkDongho KangKiyoung Kim
    • G06F21/00
    • G06F21/577
    • The present invention relates to a security apparatus and method for an all-in-one mobile device using a security profile. According to the security apparatus and method for an all-in-one mobile device using a security profile, a security profile of the mobile device is set in a manual mode or an automatic mode according to a user's knowledge level for security, and when environmental factors of the mobile device vary or the user requests to change a security level, the security profile is dynamically or statically reconstructed. This structure can rapidly solve a security problem and enables a user having a low knowledge level for security and a low degree of understanding of the functions of the mobile device to easily set a security function.
    • 本发明涉及使用安全简档的一体式移动设备的安全装置和方法。 根据使用安全简档的一体式移动设备的安全装置和方法,根据用户的安全知识水平将移动设备的安全简档设置为手动模式或自动模式,并且当环境 移动设备的因素变化或用户请求改变安全级别,安全配置文件被动态地或静态地重建。 该结构可以快速地解决安全问题,并且使具有低知识水平的用户的安全性和对移动设备的功能的低度理解以容易地设置安全功能。
    • 4. 发明申请
    • PORTABLE TERMINAL AND METHOD OF CONTROLLING EXTERNAL INTERFACE THEREOF
    • 便携式终端和控制其外部接口的方法
    • US20100037239A1
    • 2010-02-11
    • US12475079
    • 2009-05-29
    • Minho HanBoheung ChungKiyoung Kim
    • Minho HanBoheung ChungKiyoung Kim
    • G06F9/44
    • G06F21/54
    • The present invention relates to a portable terminal and a method of controlling an external interface thereof. When a system call that requests to open a external interface is input from a user process in a portable terminal that is connected to a plurality of external interfaces, a driver of the external interface is opened or intercepted using an external interface policy where open or intercepted information for each of the plurality of external interfaces is recorded to correspond to the user process. According to the present invention, an external interface that is not used by the portable terminal can be prevented from operating if externally attacked regardless of the user's intention.
    • 本发明涉及便携式终端及其外部接口的控制方法。 当从连接到多个外部接口的便携式终端中的用户进程输入要求打开外部接口的系统调用时,使用外部接口策略打开或拦截外部接口的驱动程序,打开或拦截 记录多个外部接口中的每一个的信息以对应于用户进程。 根据本发明,无论用户的意图如何,如果外部受到攻击,则可以防止便携式终端不使用的外部接口进行操作。
    • 6. 发明授权
    • Composition comprising Hovenia dulcis thunb. extract, Lindera obtusiloba blume extract, or herbal mixture extract thereof
    • 组成包括枸杞子 提取物,丁草提取物或其草药混合物提取物
    • US07846484B2
    • 2010-12-07
    • US12465830
    • 2009-05-14
    • Kiyoung KimKwangsang Kim
    • Kiyoung KimKwangsang Kim
    • A61K36/00
    • A61K36/72A23L33/105A61K36/54A61K2300/00
    • The present invention relates to a method for treating or preventing fibrosis and improving kidney function comprising administering a Hovenia dulcis Thunb extract and/or a Lindera obtusiloba extract to the subject. The method of the present invention can lower the level of GOT, GPT, ALP, BUN and total bilirubin; improve kidney functions; lower the amount of hydroxyproline in liver but increase the amount of hydroxyproline in kidney, suggesting that the extract above has excellent anti-fibrosis and kidney protecting effects; lower the level of malondialdehyde, suggesting that the extract has excellent anti-oxidative effect; and promote cell viability in liver and kidney cell lines, indicating that the extract has excellent liver and kidney cell protective effects.
    • 本发明涉及一种治疗或预​​防纤维化和改善肾功能的方法,其包括向受试者施用枸杞子提取物和/或枸杞子提取物。 本发明的方法可降低GOT,GPT,ALP,BUN和总胆红素水平; 改善肾功能; 降低肝脏中羟脯氨酸的含量,但增加肾脏中羟脯氨酸的含量,提示上述提取物具有优异的抗纤维化和肾脏保护作用; 降低丙二醛水平,提示提取物具有优异的抗氧化作用; 促进肝肾细胞系细胞活力,说明提取物具有优良的肝肾细胞保护作用。
    • 7. 发明申请
    • Composition Comprising Hovenia Dulcis Thunb. Extract, Lindera Obtusiloba Blume Extract, or Herbal Mixture Extract Thereof
    • 组成包括鄂尔多尼亚Dulcis Thunb。 提取物,枸杞子提取物,或草药混合物提取物
    • US20090285914A1
    • 2009-11-19
    • US12465830
    • 2009-05-14
    • Kiyoung Kim
    • Kiyoung Kim
    • A61K36/72A61K36/54A61P13/12
    • A61K36/72A23L33/105A61K36/54A61K2300/00
    • The present invention relates to a method for treating or preventing fibrosis and improving kidney function comprising administering a Hovenia dulcis Thunb extract and/or a Lindera obtusiloba extract to the subject. The method of the present invention can lower the level of GOT, GPT, ALP, BUN and total bilirubin; improve kidney functions; lower the amount of hydroxyproline in liver but increase the amount of hydroxyproline in kidney, suggesting that the extract above has excellent anti-fibrosis and kidney protecting effects; lower the level of malondialdehyde, suggesting that the extract has excellent anti-oxidative effect; and promote cell viability in liver and kidney cell lines, indicating that the extract has excellent liver and kidney cell protective effects.
    • 本发明涉及一种治疗或预​​防纤维化和改善肾功能的方法,其包括向受试者施用枸杞子提取物和/或枸杞子提取物。 本发明的方法可降低GOT,GPT,ALP,BUN和总胆红素水平; 改善肾功能; 降低肝脏中羟脯氨酸的含量,但增加肾脏中羟脯氨酸的含量,提示上述提取物具有优异的抗纤维化和肾脏保护作用; 降低丙二醛水平,提示提取物具有优异的抗氧化作用; 促进肝肾细胞系细胞活力,说明提取物具有优良的肝肾细胞保护作用。
    • 9. 发明申请
    • Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof
    • 组合物包括丹皮酚 提取物,丁香提取物或其草药混合物提取物
    • US20070160699A1
    • 2007-07-12
    • US10587286
    • 2005-01-31
    • Kiyoung Kim
    • Kiyoung Kim
    • A61K36/72
    • A61K36/72A23L33/105A61K36/54A61K2300/00
    • The present invention relates to a composition comprising Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof as an effective ingredient. Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof of the present invention is highly effective for the improvement of liver functions since it can lower the level of GOT, GPT, ALP, BUN and total bilirubin, which are major liver function indices. ALP and BUN are also used as kidney function indices, so the decrease of the level of ALP and BUN by the extract of the present invention indicates that Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof of the invention can improve kidney functions as well. Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof of the present invention also can lower the amount of hydroxyproline in liver but increase the amount of hydroxyproline in kidney, suggesting that the extract above has excellent anti-fibrosis and kidney protecting effects. In addition, Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof of the present invention can lower the level of malondialdehyde, an index of lipid peroxidation in liver and kidney tissues, suggesting that the extract has excellent anti-oxidative effect. Hovenia dulcis Thunb extract, Lindera obtusiloba extract or herbal mixture extract thereof of the present invention promotes cell viability in liver and kidney cell lines, indicating that the extract has excellent liver and kidney cell protective effects. Therefore, the composition of the present invention can be effectively used not only for anti-oxidation and anti-fibrosis but also for the protection and the improvement of liver and kidney functions.
    • 本发明涉及一种组合物,其包含枸杞子提取物,丁草提取物或其草药混合物提取物作为有效成分。 本发明的枸杞提取物,枸杞子提取物或其草药混合物提取物对肝功能的改善是非常有效的,因为它可以降低作为主要肝功能指标的GOT,GPT,ALP,BUN和总胆红素水平 。 ALP和BUN也用作肾功能指标,因此本发明提取物的ALP和BUN水平的降低表明本发明的枸杞提取物,白芷提取物或其草药混合物提取物可以改善肾功能 以及。 本发明的枸杞提取物,枸杞子提取物或其草药混合物提取物也可以降低肝脏中羟基脯氨酸的含量,但增加肾中羟脯氨酸的量,这表明上述提取物具有优异的抗纤维化和肾脏保护作用。 此外,本发明的枸杞提取物,枸杞子提取物或其草药混合物提取物可以降低丙二醛的水平,这是肝和肾组织中的脂质过氧化指标,表明该提取物具有优异的抗氧化作用。 本发明的枸杞提取物,枸杞子提取物或其草药混合物提取物促进肝细胞和肾细胞系中的细胞活力,表明该提取物具有优异的肝和肾细胞保护作用。 因此,本发明的组合物不仅可以有效地用于抗氧化和抗纤维化,而且可以有效地用于肝肾功能的保护和改善。